Quintrio
Home

SERVICES-PERSONAL SERVICES

Dolphin Entertainment, Inc.

DLPN

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing, and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials. The company operates within the U.S.

Last trade $0.00
Day change $0.00 (0.00%)
Day range $0.9646 – $1.02
Volume 5,794
Market cap $13M

Open XNAS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$12.64M
Price / earnings
—
Price / book
1.96×
Price / sales
0.21×
EV / sales
0.44×
EV / EBITDA
38.75×

Profitability

Earnings per share
-$0.23
Return on assets
-5.35%
Return on equity
-47.19%
Dividend yield
0%

Liquidity and leverage

Debt / equity
3.34×
Current ratio
0.86×
Quick ratio
0.86×
Cash ratio
0.28×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$1.12M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for DLPN, quarterly periods
Line itemQ3 FY2026 Sep 30, 2026Q2 FY2026 Jun 30, 2026Q1 FY2026 Mar 31, 2026Q4 FY2025 Dec 31, 2025Q3 FY2025 Sep 30, 2025Q2 FY2025 Jun 30, 2025Q1 FY2025 Mar 31, 2025Q4 FY2024 Dec 31, 2024
Revenue$16.02M$14.44M$12.8M$15.65M$14.8M$14.09M$12.17M$12.32M
Cost of revenue$861.88K$1.03M$784.65K$539.36K$643.93K$742.17K$344.41K$476.42K
Gross profit$15.16M$13.41M$12.02M$15.11M$14.15M$13.35M$11.83M$11.84M
Selling, general and administrative$13.8M$13.91M$13.62M$13.8M$13.25M$12.81M$12.59M$12.53M
Research and development$0$0$0$0$0$0$0$0
Total operating expenses$14.34M$14.45M$14.16M$14.38M$13.84M$13.4M$13.6M$13.22M
Operating income$823.55K-$1.03M-$2.14M$726.65K$308.3K-$57.05K-$1.77M-$1.38M
Interest expense-$612.3K-$578.57K-$547.95K-$445.76K-$627.95K-$561.22K-$554.01K-$510.92K
Income before taxes$223.96K-$1.59M-$2.67M$1.05M-$365.49K-$1.39M-$2.31M-$1.92M
Income taxes-$6.32K$17.65K$17.65K$26.32K$0$21.52K$21.52K$43.15K
Net income$230.28K-$1.61M-$2.69M$1.02M-$365.49K-$1.41M-$2.33M-$1.96M
Net income attributable to common shareholders$228.28K-$1.61M-$2.69M$1.02M-$365.49K-$1.41M-$2.33M-$1.96M
EBITDA$1.36M-$497.1K-$1.6M$1.41M$897.68K$534.5K-$765.8K$1.04M
Basic earnings per share$0.02-$0.13-$0.22$0.08-$0.03-$0.13-$0.21-$0.17
Diluted earnings per share$0.02-$0.13-$0.22$0.08-$0.03-$0.13-$0.21-$0.17

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Investing.com

Actions Speak Louder: Why This CEO Kept Buying His Own Stock

Dolphin Entertainment CEO William O'Dowd IV executed over 35 open-market stock purchases throughout 2025, accumulating nearly 19.30% ownership and deploying approximately $100,000 in personal capital. This aggressive buying pattern, including a major 85,000-share purchase in August, signals strong conviction in the company's valuation. The CEO's actions are supported by improving financials—Q3 2025 showed 16.7% revenue growth to $14.8 million and a narrowed net loss to $365,000—and a strategic shift toward scalable assets like the feature film Youngblood (theatrical release March 2026) and the Always Alpha women's sports division, which offer better margins than traditional PR services.

Benzinga

Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Session

Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share. Fresh Vine Wine, Inc. (NYSE: VINE) gained 70.1% to $0.3845. Fresh Vine Wine recently announced the appointment of Hitesh Dheri as Chief Financial Officer and Secretary. Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 65.1% to $6.32. Advanced Health Intelligence recently announced the implementation of an ADS ratio change. SQZ Biotechnologies Company (NYSE: SQZ) shares gained 46.1% to $0.3944 after declining 11% on Friday. IMAC Holdings, Inc. (NASDAQ: BACK) shares jumped 38.6% to $0.1524. Theralink recently signed definitive merger agreement to be acquired by IMAC Holdings. Canopy Growth Corporation (NASDAQ: CGC) gained 37% to $0.5337. Canopy Growth said that all conversions pursuant to the $100 million senior unsecured convertible debentures, sold to an institutional investor in February 2023, have been completed. Ensysce Biosciences, Inc. (NASDAQ: ENSC) gained 30.6% to $2.39. HC Wainwright & Co. initiated coverage on Ensysce Biosciences with a Buy rating and announced a price target of $9. Spark Networks SE (NASDAQ: LOV) rose 26.1% to $0.3974. Nemaura Medical Inc. (NASDAQ: NMRD) surged 24.6% to $1.16. Ventyx Biosciences, Inc. (NASDAQ: VTYX) gained 17.6% to $38.56. Journey Medical Corporation (NASDAQ: DERM) jumped 17.6% to $1.87. Journey Medical expects topline results from the Phase 3 clinical trials evaluating DFD-2 for the treatment of papulopustular rosacea to be announced week of July 10, 2023. ACM Research, Inc. (NASDAQ: ACMR) shares climbed 17% to $15.30 after Jefferies upgraded its rating from Underperform to Buy and raised the price target from $9 to $23.4. Micromobility.com Inc. (NASDAQ: MCOM) shares ...

Benzinga

Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday. Akouos, Inc. (NASDAQ: AKUS) shares surged 88.2% to close at $13.19 on Tuesday. Eli Lilly And Co (NYSE: LLY) agreed to acquire Akouos for a 78% premium over Monday’s closing price of $7.01. Rubicon Technologies, Inc. (NYSE: RBT) climbed 58.2% to close at $1.74. Helbiz, Inc. (NASDAQ: HLBZ) climbed 58.1% to close at $0.4211. Helbiz CEO Salvatore Palella recently acquired a total of 200,000 shares at an average price of $0.25. Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) jumped 44.4% to close at $2.73 after the company announced plans to initiate a second clinical trial in Netherton Syndrome patients. AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) gained 42.4% to close at $14.92 after LG Chem announced it will acquire AVEO Oncology for $15 per share in cash. Zovio Inc (NASDAQ: ZVO) gained 38.7% to settle at $0.20 after declining 11% on Monday. Digital Brands Group, Inc. (NASDAQ: DBGI) surged 35.3% to close at $0.1096. Eqonex Limited (NASDAQ: EQOS) rose 35.1% to close at $0.3524. Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares gained 32.5% to close at $8.16. Kiora Pharmaceuticals, on Monday, announced publication of Phase 1 trial results for KIO-100 as a treatment for ocular inflammatory disease. Eargo, Inc. (NASDAQ: EAR) surged 30.5% to close at $0.89. Eargo was granted U.S. patent titled 'Hearing Device Test And Diagnostics System And Methods.' Beyond Air, Inc. (NASDAQ: XAIR) gained 29.9% to close at $7.83. The company on Monday highlighted data from its LungFit GO pilot at-home study. Decibel Therapeutics, Inc. (NASDAQ: DBTX) climbed 25.4% to close at $3.70. Decibel Therapeutics recently received FDA clearance of IND application for DB-OTO, a gene therapy product candidate designed to provide hearing to individuals with otoferlin-related hearing loss. Oblong, Inc. (NASDAQ: OBLG) gained 25.1% to close at $0.45. Mynaric AG (NASDAQ: MYNA) rose 24.8% to settle at $7.00. Mynaric will provide optical communications terminals to Northrop Grumman as part of the Space Development Agency's Tranche 1 Tracking Layer Program. KULR Technology Group, ...

Benzinga

Why Aridis Pharmaceuticals Shares Plunged Around 30%; Here Are 81 Biggest Movers From Yesterday

Gainers LAVA Therapeutics N.V. (NASDAQ: LVTX) shares climbed 97.5% to close at $4.74 on Monday after the company and Seagen Inc (NASDAQ: SGEN) announced an exclusive license agreement in which Seagen will work to develop, manufacture and commercialize LAVA-1223. DIRTT Environmental Solutions Ltd. (NASDAQ: DRTT) climbed 41% to close at $0.4499. Studio City International Holdings Limited (NYSE: MSC) climbed 36.9% to close at $2.45. Panbela Therapeutics, Inc. (NASDAQ: PBLA) gained 26% to close at $0.3401. Melco Resorts & Entertainment Limited (NASDAQ: MLCO) rose 25.5% to close at $6.65 after Macau officials signaled that COVID-19 travel restrictions will be lifted. Citigroup analyst George Choi also maintained Melco with a Buy rating and raised the price target from $11 to $11.50. Polar Power, Inc. (NASDAQ: POLA) gained 25.4% to settle at $3.16. Alaunos Therapeutics, Inc. (NASDAQ: TCRT) climbed 24.3% to close at $2.15. Pioneer Power Solutions, Inc. (NASDAQ: PPSI) rose 23.5% to close at $3.99. Pioneer Power Solutions, last month, said Q2 EPS results were down year over year. Heliogen, Inc. (NYSE: HLGN) gained 23.2% to close at $1.70. HeartBeam, Inc. (NASDAQ: BEAT) rose 22.2% to settle at $2.48. Inpixon (NASDAQ: INPX) jumped 21.5% to close at $0.1407 after the company announced it signed a definitive merger agreement with KINS Technology for KINS to acquire Inpixon's enterprise apps business. AEA-Bridges Impact Corp. (NYSE: IMPX) gained 20.7% to close at $9.39. FingerMotion, Inc. (NASDAQ: FNGR) gained 19.7% to close at $0.7896. Mannatech, Incorporated (NASDAQ: MTEX) surged 18.4% to close at $22.80. GreenLight Biosciences Holdings (NASDAQ: GRNA) gained 18.2% to settle at $2.27. Pulse Biosciences, Inc. (NASDAQ: PLSE) surged 17.5% to close at $1.81 after the company announced FDA 510(k) clearance for the treatment of sebaceous hyperplasia. MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) climbed 17.1% to close at $2.60. Allied Healthcare Products, Inc. (NASDAQ: AHPI) gained 17.1% to close at $1.71. Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 16.2% to settle at $1.87. 374Water, Inc. (NASDAQ: SCWO) gained 15.4% to close at $3.45. Aditxt, Inc. (NASDAQ: ADTX) shares climbed 14.7% to close at $3.05 after amended 13G filing showed a 9.9% stake from Intracoastal Capital LLC. Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) rose 14.1% to settle at $0.5888. SES AI Corporation (NYSE: SES) gained 14.1% to settle at $5.09. Vapotherm, Inc. (NYSE: VAPO) surged 13.9% to close at $1.64. Shift Technologies, Inc. (NASDAQ: SFT) surged 12.7% to settle at $0.7350. Wynn Resorts, Limited (NASDAQ: WYNN) gained 12% to close at $66.80 after Macau officials signaled that COVID-19 travel restrictions will be lifted. Citigroup analyst George Choi also maintained Wynn with a Buy rating and raised the price ...

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Oct 16, 20241-for-2reverse split
Nov 27, 20201-for-5reverse split